Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07348796 · ClinicalTrials.gov registry record · NA
Real World Evaluation of the Effectiveness and Implementation of a Digital Health Therapeutic for OUD
A NA study, sponsored by The University of Texas Health Science Center at San Antonio.
- Not yet
- Registry status
- NA
- Development phase
- 134
- Enrollment target
NCT07348796: Clinical Trial NA study, sponsored by The University of Texas Health Science Center at San Antonio.
NCT07348796 is a NA study that has not yet begun recruiting, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 134 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07348796, a NA study, has not yet begun recruiting, sponsored by The University of Texas Health Science Center at San Antonio.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
Study Summary
The researchers will study the KIOS app, a digital health tool made to help people recovering from opioid addiction take better care of themselves. They want to see how the app works in real life and learn who benefits most from using it. The study will also ask participants what they think about the app and how easy it is to use.
Primary Outcome
The number of days from the start of the one-year intervention until the participant either leaves the trial or completes the trial.
Interventions
- DEVICE KIOS App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2026-07-15 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
What is known before NCT07348796 opens enrollment
NCT07348796 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which KIOS App is the first listed.
NCT07348796 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07348796 about?
NCT07348796 is a clinical study titled "Real World Evaluation of the Effectiveness and Implementation of a Digital Health Therapeutic for OUD". The researchers will study the KIOS app, a digital health tool made to help people recovering from opioid addiction take better care of themselves. They want to see how the app works in real life and learn who benefits most from using it. The study will also ask participants what they think about th...
What is the current status of trial NCT07348796?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 134 participants. The study started on 2026-07-15. Estimated completion is 2027-08-31.
What interventions are being tested in trial NCT07348796?
The interventions under investigation include: KIOS App (DEVICE).
Who is sponsoring clinical trial NCT07348796?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07348796's enrollment target sits among peer trials
134 728th of 2000 higher than 1,272 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI